Ladenburg Thalmann Financial Services’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 5150 |
|
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 5230 |
|
|
2019
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 5228 |
|
|
2019
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 5174 |
|
|
2018
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 5454 |
|
|
2018
Q3 | $1K | Sell |
300
-2,579
| -90% | -$8.6K | ﹤0.01% | 5094 |
|
|
2018
Q2 | $11K | Hold |
2,879
| – | – | ﹤0.01% | 4224 |
|
|
2018
Q1 | $11K | Sell |
2,879
-400
| -12% | -$1.53K | ﹤0.01% | 4224 |
|
|
2017
Q4 | $9K | Buy |
3,279
+1,200
| +58% | +$3.29K | ﹤0.01% | 4270 |
|
|
2017
Q3 | $9K | Sell |
2,079
-500
| -19% | -$2.17K | ﹤0.01% | 4153 |
|
|
2017
Q2 | $12K | Sell |
2,579
-6,900
| -73% | -$32.1K | ﹤0.01% | 3928 |
|
|
2017
Q1 | $40K | Buy |
9,479
+9,400
| +11,899% | +$39.7K | ﹤0.01% | 3084 |
|
|
2016
Q4 | $0 | Sell |
79
-100
| -56% | – | ﹤0.01% | 5015 |
|
|
2016
Q3 | $2K | Hold |
179
| – | – | ﹤0.01% | 4545 |
|
|
2016
Q2 | $2K | Sell |
179
-2,975
| -94% | -$33.2K | ﹤0.01% | 4472 |
|
|
2016
Q1 | $25K | Sell |
3,154
-2,100
| -40% | -$16.6K | ﹤0.01% | 3114 |
|
|
2015
Q4 | $57K | Sell |
5,254
-9,058
| -63% | -$98.3K | ﹤0.01% | 2466 |
|
|
2015
Q3 | $99K | Hold |
14,312
| – | – | ﹤0.01% | 2003 |
|
|
2015
Q2 | $127K | Hold |
14,312
| – | – | ﹤0.01% | 1932 |
|
|
2015
Q1 | $141K | Hold |
14,312
| – | – | ﹤0.01% | 1828 |
|
|
2014
Q4 | $175K | Sell |
14,312
-460
| -3% | -$5.63K | ﹤0.01% | 1529 |
|
|
2014
Q3 | $147K | Sell |
14,772
-740
| -5% | -$7.36K | ﹤0.01% | 1377 |
|
|
2014
Q2 | $117K | Sell |
15,512
-12,188
| -44% | -$91.9K | ﹤0.01% | 1507 |
|
|
2014
Q1 | $91K | Buy |
27,700
+12,700
| +85% | +$41.7K | ﹤0.01% | 1563 |
|
|
2013
Q4 | $50K | Buy |
15,000
+12,500
| +500% | +$41.7K | ﹤0.01% | 1923 |
|
|
2013
Q3 | $8K | Hold |
2,500
| – | – | ﹤0.01% | 2983 |
|
|
2013
Q2 | $20K | Buy |
+2,500
| New | +$20K | ﹤0.01% | 2357 |
|